Abstract: Microtubules are cytoskeletal filaments that serve as attractive scaffolds for developing nanomaterials and nanodevices because of their unique structural properties. The functionalization of the outer surfaceo fmicrotubules has been established for this purpose. However,n oa ttempts have been made to encapsulate molecules inside microtubules with 15 nm inner diameter.T he encapsulationo fv arious molecularc argos inside microtubulesc onstitutes an ew concept for nanodevice and nanocarrier applicationso fm icrotubules. Here, we developed peptidem otifs for binding to the inner surface of microtubules,b ased on ar epeat domain of the microtubule-associated protein Ta u. One of the four Ta u-derived peptides, 2 N ,b inds to at axol binding pocket of b-tubulin located inside microtubules by preincubation with tubulin dimer and subsequentp olymerization of the peptide-tubulinc omplex. By conjugation of 2 N to gold nanoparticles, encapsulation of gold nanoparticles inside microtubules was achieved. The methodology form olecular encapsulationi nside microtubules by the Tau-derived peptide is expectedt oa dvance the development of microtubule-based nanomaterials and nanodevices.
Introduction
Biosupramolecular assemblies, includingc ytoskeletal filaments (microtubules, F-actin,a nd intermediate filaments), amyloid fibrils, and collagen fibrils, have been utilized to develop nanomaterials andn anodevices by templating the highly regulated assembled structures. [1, 2] Especially,m icrotubules, which are hollow tubes formed by polymerization of tubulin dimers (aand b-tubulin), are attractive molecular scaffolds because of their uniques tructural properties. [3] [4] [5] [6] [7] [8] [9] [10] Directional transport of variousc argos on microtubules has been established by using motor proteins( kinesin and dynein), which move along microtubulesp owered by ATP. [11] [12] [13] [14] [15] [16] The accumulation of metal nanoparticles on the outer surface of microtubules has been reported by Behrens et al. [17] [18] [19] and other groups. [20] [21] [22] [23] Dynamic selforganization of microtubules and their associatedm otor proteins has been utilized to form unique nanostructures such as asters,n etworks,a nd rings. [24] [25] [26] [27] [28] Although the functionalization of the outer surfaceo fm icrotubules has been established for the examples mentioned above,n oa ttempts have been made to encapsulate molecules inside microtubules. Molecular encapsulation inside microtubules with large internal space (15 nm inner diameter) is thus an ew concept for the fabrication of microtubule-based nanomaterials and nanodevices. The encapsulated cargos are transported by the kinesin-based motor system and released due to the depolymerization capability of the microtubules. Although taxol is known to bind to ap ocket of b-tubulin located inside microtubules, [29] the use of at axol scaffold for molecular encapsulation in microtubules has not been reported, which is probably due to the complex structure and limitedn umber of reactive groups that can be used for functionalization, restricting the conjugation of taxol with cargo molecules. Thus, an ew methodology is required to encapsulate various molecular cargosinm icrotubules.
To design new motifs for the binding to the inner surface of microtubules, we focusedo nT au, which is one of the microtubule-associated proteins. [30] It is known that Ta us tabilizes microtubules and promotes their assembly by interacting with tubulin and the microtubules (Figure 1a) . [31] The microtubulebinding region of Ta uc onsistso fi mperfect repeat sequences (R1, R2, R3, and R4) linked by interrepeats equences (Fig-ure 1b) . Various binding modelsh ave been proposedf or the repeatso ft he full-length Ta uw ith tubulin and microtubules. [32] [33] [34] [35] [36] [37] [38] [39] Amos et al.l abeled the full-length Ta uw ith ag old nanoparticle (AuNP) in ap osition of the repeatd omain of Ta u to analyze the localization of the repeatd omain when bound to microtubules. [32] The AuNP was located close to the taxol binding pocket of b-tubulin, suggesting the binding of the repeat domain in Ta ut ot he inner surfaceo ft he microtubules. Based on their study,aconservedP GGG motif in the repeats is important for the binding to the pocket. An NMR study has shown that parts of the R1-interrepeat (269-284) and R2-interrepeat (298-312) of Tauf orm ah airpin conformation around the PGGG motif upon bindingt ot he microtubules (Figure 1b) . [34] Thus,t he two Ta ud omains are attractive candidates for motifs binding to the inner surface of microtubules. Althoughavariety of Taup eptides were investigated to evaluate the binding of Ta ut om icrotubules, [40] [41] [42] [43] [44] [45] [46] [47] [48] thesep eptides have not been utilized for molecular encapsulationi nside microtubules.
Herein,w edeveloped four peptides based on the repeat domain of Tauf or the binding to the inner surface of microtubules (Figure 1b) . One of the four Ta u-derived peptides binds to at axol binding pocket by complexation with tubulin and subsequentp olymerization (Figure 1c ). We also demonstrate that the peptidei su seful for encapsulating AuNPs inside microtubules by the formation of peptide-AuNP conjugates.
Results

Design of the microtubule-bindingpeptides
The bindingo fp arts of the Ta ur epeatst ot ubulin was modeled by molecularm echanics (MM) calculations using aM acroModelm odule (see Experimental Section).T he two reported hairpin structures, residues 267-284 (sequence 1)a nd 298-315 (sequence 2), were extracted and modified from Tau( 267-312) [34] and put into at axol binding pocket of b-tubulin [49] by replacing at axol. The modeled structures show that the core hairpin motifs (PGGGKVQII for 1 and PGGGSVQIV for 2)f it well into the taxol binding pocket (Figure 2a nd S1) . The results agree with the previous hypothesis that the hairpin is am olecular hook anchoring Ta ut om icrotubules by insertion into the pocket of b-tubulin. [32, 34] We designed the Ta u-derived peptides 1 N , 1 C , 2 N ,a nd 2 C by introducing cysteines to the N-or C-terminal of 1 and 2 using af lexible linker (GGG) for the conjugation of af luorescentd ye (Figure 1b) . The peptides were synthesized by standard solid-phase 9-fluorenylmethyloxycarbonyl (Fmoc) chemistry,p urified by reverse-phaseh igh-performance liquid chromatography (RP-HPLC), andc onfirmed by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry (MALDI-TOF-MS;F igures S2a-d). To monitor the binding of 1 N , 1 C , 2 N ,a nd 2 C to tubulin andm icrotubules, cysteine residues of the peptides were conjugatedw ith ar ed fluorescent tetramethylrhodamine (TMR)-5-maleimide.T he TMR-peptides (1 N -TMR, 1 C -TMR, 2 N -TMR,a nd 2 C -TMR)w ere purifiedb yR P-HPLC and the conjugation of TMR wasc onfirmedb yM ALDI-TOF-MS (Figures S2e-h) .
Bindingaffinity of the TMR-labeled peptides to tubulin
We investigated the binding of TMR-peptides to tubulin by equilibriumd ialysis (see Experimental Section). TMR-peptides were incubated with tubulin at variousc oncentrations and dialyzed, then the fluorescence intensity of the dialyzed bulk solution was measured ( Figure S3 ). The dissociation constant (K d ) and binding site occupancy (n)o fT MR-peptidep er tubulin were estimated by fitting the data using aq uadratic binding equation( Ta ble1). All TMR-peptides show ah igher affinity compared with the reported interrepeat-R1 of Ta u( 244-277) (K d = 64.1 mm) [47] and taxol derivative(
. [50] Bindinganalysis of the TMR-labeled peptides to microtubulesbyC LSM Binding of the TMR-peptides to microtubules was observed by confocall aser scanning microscopy (CLSM). To monitor the microtubules, ag reen fluorescent Alexa Fluor 430 (AF) was conjugated with tubulin (tubulin-AF) based on ap reviously reported method. [51] Given that it has been reported that the repeat domain of Ta ub inds to the taxol binding pocket when Ta u and tubulin are co-assembled before microtubule formation, [32, 36] we added the TMR-peptides before microtubule formation ("Before" method; Figure 1c ). In this method, tubulin and tubulin-AF were preincubated with the TMR-peptides for 30 min at 25 8Ca nd then polymerized for 30 min at 37 8Ct o form microtubules by incubation with guanosine-5'-[(a,b)-methyleno]triphosphate (GMPCPP), which is as lowly hydrolysable GTP analogue that is used to form stabilized microtubules. [52] The binding of all of the four TMR-peptides onto microtubules was confirmed by colocalization of red fluorescent TMR-peptides and green fluorescent labeled microtubules ( Figure 3 ). For comparison, the TMR-peptides were added to GMPCPP-stabilized microtubules ("After"m ethod). Even using the "After" method, the four TMR-peptides were bound to microtubules ( Figure S4 ). Binding of 5(6)-carboxytetramethylrhodamine (TMR-COOH)t om icrotubules was not observed in the "Before" and "After" methods ( Figure S5 ), indicating the importance of peptidemoietiesf or the binding.
To confirm whether the TMR-peptides were bound to the taxol binding pocket of the microtubules,c ompetition binding experiments of taxol with TMR-peptide-incorporatedm icrotubules were carried out. Considering that the binding of taxol to a b-tubulin pocket of GMPCPP-stabilized microtubules is strong (K d = 10 nm), [53] it is expected that the TMR-peptides bound to the taxol-binding pocket are replaced with taxol (Figure 4a) . When 2 N -TMR-incorporated microtubules were prepared by using the "Before" method, the TMR fluorescenceo n microtubules was dramatically decreased by taxol (Figure 4b ), indicating the binding of 2 N -TMR to the taxol binding pocket. [b] 49 -
[a] Reported value for the binding to growing microtubules. [47] [b] Reported value for the binding to tubulin. [50] However, 2 N -TMR was still bound to microtubules even after taxol treatment when prepared by the "After" method (Figure 4b) . To estimate the amount of TMR-peptides on microtubules, the ratio of the TMR and AF fluorescence intensity of each microtubule was calculated from the CLSM images. The TMR/AFr atio of 2 N -TMR-incorporated microtubules decreases with increasing taxol concentration in the "Before" method, whereas the ratio is not affected in the "After" method ( Figure 4c ). This comparison demonstrates that 2 N -TMR binds to the taxol binding pocket only when it is preincubated with tubulin. The TMR/AF ratios of microtubules incorporatedw ith other TMR-peptides, 1 N -TMR, 1 C -TMR,a nd 2 C -TMR are not significantlyi nfluencedb yt axol in both the "Before" and" After" methods (Figure4d-f). These results indicatet hat the main binding sites of 1 N -TMR, 1 C -TMR,a nd 2 C -TMR are not the taxol binding pocket even in the "Before" method.
To investigate the binding site of 2 N -TMR in the "After" methoda nd 1 N -TMR, 1 C -TMR,a nd 2 C -TMR in the "Before" and "After" methods, we used an anti-tubulin antibody that binds to the C-terminal region of tubulin on the outer surface of the microtubules. The C-terminal regioni sk nown as one of the bindings ites of Tau. [54] The treatment of the antibody to GMPGPP-stabilized microtubules and subsequenta ddition of 2 N -TMR ("After" method)i nduce al arge decrease of the TMR/ AF ratio (Figures 5a and b), indicatingt he binding of 2 N -TMR on the outer surface of microtubules. Given that the TMR/AF ratio is not influenced by the antibody when prepared by the "Before" method( Figure 5a andb ), the main bindings ite of 2 N -TMR in the "Before" methodi st he inner surface of the microtubules, not the outer surface. These results are in good agreement with the competition binding experimentsu sing taxol (Figure 4c ). The TMR/AFr atios of 1 N -TMR-, 1 C -TMR-, and 2 C -TMR-incorporated microtubules in both the "Before" and "After" methods dramatically decrease upon antibodyt reatment (Figure 5c-e), indicating that the main binding sites of 1 N -TMR, 1 C -TMR,a nd 2 C -TMR are on the outer surface of the microtubules.T he binding models of TMR-peptides to microtubules in the "Before" and "After" methods are summarizedi n Figure 6 . In the "Before" method, 2 N -TMR binds to the taxol binding pocket to form the 2 N -TMR-encapsulated microtubules,w hereas other TMR-peptidesm ay bind to the C-terminal regiono ft ubulin, resulting in the accumulation of the TMRpeptideso nt he outer surface( Figure6a). Although the sequenceo f2 N and 2 C are similar,t he binding sites are different in the "Before" method. MM calculations show that the minima conformations of 2 N are close to the binding conformation in the taxol binding pocket compared with that of 2 C (see Experimental Section, Figure S6 ). Thus, 2 N may easily form the bind- ing conformation comparedw ith 2 C ,e xplaining why 2 N can bind to the pocket but 2 C cannot. In the "After" method,a ll of the four TMR-peptides bind to the outer surface of microtubules (Figure 6b ). Thus, only 2 N -TMR binds to the inner surface of microtubules by preparation with the "Before" method.
Effect of Tau-derived peptides on tubulin polymerization
To evaluatet he effect of the binding of Ta u-derived peptides on tubulin polymerization, we carried out turbidity measurements.T he addition of 2 N to tubulin in the presence of GTP at 37 8Ci ncreasest he turbidity (opticald ensity at 350 nm) due to tubulin polymerization,w hereas other peptides (1 N , 1 C ,a nd 2 C ) are lesse ffective ( Figure 7) . The results indicate that the binding of 2 N at the taxol binding site promotes tubulin polymerization, similart ot he effect of taxol. [29] The binding of the other three peptides to the outer surfaceo ft he microtubules has little influence on tubulin polymerization. Interestingly,t he 2 Ntreated microtubules completelyd epolymerized when decreasing the temperature to 4 8C, whereas taxol-treatedm icrotubules remained stable ( Figure 7) . Thus, the 2 N -treated microtu- bules are less stable than the taxol-treated microtubules.T he reversible polymerization/depolymerization capability is useful for the encapsulation/release of molecular cargosi nm icrotubules, even upon bindingw ith 2 N .
Encapsulation of AuNPsinside microtubules
To evaluate the molecular encapsulation capability of 2 N inside microtubules, 2 N was conjugated with 5nmA uNPs by thiolgold interaction. Tubulin was incubated with the 2 N -AuNP conjugates and then polymerizedb yG MPCPP( "Before" method; Figure 8a ). The accumulation of 2 N -AuNPs on both the inside and outside of the microtubules was observed by transmission electron microscopy (TEM;F igure8b( left) and S7). By treatment of the anti-tubulina ntibody, 2 N -AuNPs on the outer surface were removed (Figure 8b (right)a nd S8) . When 2 N -AuNPs were added to preassembled microtubules ("After"m ethod), 2 N -AuNPs accumulatedm ainly on the outer surfaceo ft he microtubules (Figure 8c (left) and S9) and were removedb yt he anti-tubulina ntibody (Figure 8c (right) and S10). For analysis of the distribution of 2 N -AuNPs,t he number of 2 N -AuNPs binding to the inner surface and outer surface of microtubules was counted from the TEM images (Figures 8d). In the "Before" method, 2 N -AuNPs were efficientlyb ound to the inner surface of microtubules (ca. 10 AuNPsp er microtubule) compared with the "After" method( Figure8d). By treatment of the antitubulin antibody, the amount of 2 N -AuNPsb inding to the outer surface of microtubules was decreased in both the "Before" and "After" methods, whereas the amount of 2 NAuNPs inside microtubules was not affected by the treatment (Figure 8d ). The encapsulation of 2 N -AuNPs inside microtubules only by the "Before" methodi si ng ood agreement with the binding properties of 2 N -TMR.The AuNPswithout conjugation of 2 N did not efficiently accumulate inside microtubules, even when using the "Before" method ( Figure 8d and Figure S11 ). These results demonstrate that the conjugation of 2 N is au seful methodology to encapsulate AuNPs in microtubules.
Discussion
In this study,f our peptides were designed from the repeat domain of Tauf or molecular encapsulationi nside microtubules (Figure 1 ). Addition of taxol to 2 N -TMR-incorporatedm icrotubules in the "Before" method decreased the fluorescenceo f 2 N -TMR from microtubules (Figure 4c ), indicatingt he binding of 2 N -TMR in the taxol-binding site. Alternatively,e ven if the binding site of 2 N -TMR is not the taxol-binding site, it is possible that the bindingo ft axol induces ac onformational change in tubulin, whicha ffects the binding of 2 N -TMR.H owever,b ecause treatment of the anti-tubulina ntibodyd id not affect the binding of 2 N -TMR on microtubules in the "Before" method (Figure 5b) , the bindings ite of 2 N -TMR is not on the outer surface. In addition, turbidity assay suggests that 2 N binds to a taxol-binding site to induce tubulinp olymerization (Figure 7) . Although the binding stoichiometry of 2 N to tubulin is low (Table 1) , it is sufficient to affect tubulinp olymerization because as mall number of boundt axol per tubulin can stabilize microtubules. [55] As ad irect evidenceo fm olecular encapsulation inside microtubules by using 2 N ,w eo bserved the encap- sulationo f2 N -conjugated AuNPs inside microtubules by the "Before" method ( Figure 8 ). In the "Before" method, the amount of 2 N -AuNPs inside microtubules was not significantly changed by treatment of the anti-tubulin antibody,w hereas 2 N -AuNPs binding to the outers urface were released by the treatment (Figure 8d ). These results indicate that 2 N -AuNPs were encapsulated inside microtubules and the counted 2 NAuNPs inside microtubules were not due to the miscount of the 2 N -AuNPs on the outer surface. Amos et al. showedt hat the repeatd omain of full-length Ta uc onjugated with AuNP binds to the taxol-binding site of microtubules. [32] Compared to the study,w es howedt hat as mallp eptide 2 N from Ta ui s enought ob ind to the inside of microtubules and encapsulate AuNPs inside microtubules. In addition, binding sites of 2 N can be modulated to the inner surface or outer surface of microtubules, dependent on the "Before" or "After" methods,r espectively ( Figure 6 ). Thus, molecular cargos can be introduced to the inside or outer surface of microtubules by using 2 N ,according to the purpose.
Our results indicatet hat 2 N -TMR binds to the taxol-binding site in the "Before" method, whereas the binding site is the outer surface in the "After" method ( Figure 6 ). The different binding sites of 2 N -TMR in the two methods are consistent with the previous studies analyzing the binding of full-length Ta ut om icrotubules. [32, 36, 56] Cryomicroscopy measurement showedt hat the repeat domain of the full-length Taub inds to the taxol-binding site when Taua nd tubulin are co-assembled, similar to our "Before" method. [32] In contrast, when Ta ui si ncorporated to preassembled microtubules,s imilar to our "After" method, Ta ui ss olely observed on the microtubule protofilament ridges on the outer surface. [56] Lew et al. revealed that there are two distinct binding sites of Tauo nm icrotubules, dependento nt he co-assembly of Ta ua nd tubulin ("Before" method) or binding of Ta ut op reassembled microtubules ("After" method). [36] These studies suggest that Ta uh as a binding site inside microtubules, which is only foundi nt he "Before" method, similar to 2 N -TMR.M odel analysis suggested that moleculard iffusion inside microtubules through the open ends of microtubules is slow when the diffusing molecules bind to the interior surface. [57] Although small molecules such as taxol (854 Da) can enter the inside of microtubules by passing throughp ores (1.5 nm 2.0 nm) in the walls of GMPCPPmicrotubules, [58] [59] [60] the pore size is not large enoughf or 2 N -TMR (2778 Da) to enter.T hus, 2 N -TMR cannotg ot hrough the inside of preassembledm icrotubules, explaining why 2 N -TMR does not bind to the taxol-binding site inside microtubules in the "After" method.
Motilitya ssay of microtubulesw ith 2 N -TMR and 2 N -cargo conjugate on the kinesin-coated plate is an ext step to evaluate the effect of the encapsulationonthe transport of microtubules. When 2 N -cargo and kinesin are labeled with different fluorescentm olecules, which are used as ad onor and acceptori n af luorescencer esonance energy transfer (FRET)m easurement, it is possible to measure the FRET efficiency between 2 N -cargo and kinesin to obtain information about the distribution of 2 Ncargo on microtubules in the "Before" or "After" methods.I ti s also important to analyze the effecto ft he encapsulation of 2 N -TMR and 2 N -cargo on the assembly/disassemblyp rocess of microtubules. For instance, disassembly of microtubules can provide force for the membrane movement, as evaluated in the model system. [61] Thus, evaluation of motility,d ynamics, and structuralp roperties (stability,r igidity,a nd length) of microtubules with encapsulatedc argos will providei nsight into the bioactivity of microtubules.
Conclusions
We developed Ta u-derived peptidesf or molecular encapsulation in microtubules.W ed esigned four peptides with different repeats equences of Taua nd different positions of cysteine residues at the terminal. Amongt hem, TMR-labeled 2 N was bound to the taxol bindingp ocket located at the inner surface of microtubules by preincubation with tubulin and subsequent polymerization of the peptide-tubulin complex, whereas other peptides were boundo nthe outer surface of the microtubules. By conjugation of 2 N to AuNPs,A uNP-encapsulated microtubules were successfully constructed. These resultsa re proofo f the concept of molecular encapsulation inside microtubules based on natural microtubule-binding proteins. Further characterization of the precise binding site of 2 N -cargo conjugate in microtubules is under investigation. We envision that 2 N can be utilized for the encapsulationo fv arious cargos, such as metal nanoparticles, quantum dots, and proteins inside microtubules, for nanodevice and nanocarrier applications by combination with the kinesin-based transporting system and depolymerization of microtubules.
Experimental Section Equipment and materials
High-performance liquid chromatography (HPLC) was performed with aS himadzu LC-6AD liquid chromatograph with GL Science Inertsil WP300 C18 columns (4.6 mm 250 mm for analysis and 20 mm 250 mm for purification). Microwave-assisted solid-phase peptide synthesis was carried out with an Initiator + (Biotage). Matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectra were taken with aB ruker Daltonics Autoflex TII with a-cyano-4-hydroxycinnamic acid (a-CHCA) as am atrix. UV/Vis spectra were obtained with aJ asco V-630. Transmission electron microscope (TEM) was measured with aJ eol JEM 1400 Plus with a grid (C-SMART Plus TEM grid, ALLIANCE Biosystems Inc.,O saka, Japan). Confocal laser scanning microscopy (CLSM) measurement was carried out with aFluoView FV10i (Olympus). Tubulin was purified from porcine brain by using ar eported procedure. [62] The reagents used were purchased from Watanabe Chemical Ind.,L td., To kyo Chemical Industry Co.,D ojindo Laboratories Co.,L td. and Wako Pure Chemical Industries. All the chemicals were used without further purification.
Molecular modeling
MM calculations were performed with MacroModel 10.4 (Schrç-dinger,I nc.,N ew York, NY) using optimized potentials for liquid simulations (OPLS) 2005 force field with default setting. The refined structure of the a-a nd b-tubulin dimer at 3.5 resolution (PDB ID:1 JFF) [49] was used for molecular modeling and ligand docking. Addition of missing hydrogen atoms to the model was carried out using Maestro interface ver.1 0.4 (Schrçdinger) based on an explicit all atom model. As ligands, the sequences 1 (KHQPGGGKVQIINKKLDL) and 2 (KHVPGGGSVQIVYKPVDL) were extracted from residues 267-284 and 298-312 of Ta u(267-312) (PDB ID:2 MZ7), respectively. [34] The missing residues 313-315 (VDL) in the NMR structures were put to the residue 298-312 manually and the structure of residues 313-315 was energy-minimized. The sequences 1 and 2 were put to the taxol-binding pocket of b-tubulin instead of taxol. The initial positions of 1 and 2 were determined based on the criteria that 1) the N-and C-terminal of these residues are surface-exposed and 2) the hairpin structures, PGGGKVQII for 1 and PGGGSVQIV for 2 are close to the core taxane ring of taxol. Firstly, 1 and 2 with the surrounding residues around 5.0 were energy-minimized. The minimum energy conformation was then used as as tarting point for aM onte Carlo conformational search with up to 1000 search steps, an energy window of 200 kJ mol À1 for saving structures, the loosened threshold for conformer redundancy:t he root mean square deviation (RMSD) cutoff of 1.0 .I nt he calculations, 1 and 2 with its surrounding residues within 3.0 were applied for the conformational search. Finally, the obtained structures were energy-minimized by using the same parameters above.
Comparison of 2 N and 2 C in MM calculations
The binding conformations of 2 N (CGGGKHVPGGGSVQIVYKPVDL) and 2 C (KHVPGGGSVQIVYKPVDLGGGC) in the taxol-binding pocket of b-tubulin were calculated by using the procedure described above. Minima conformations of 2 N and 2 C were searched by a Monte Carlo conformational search with up to 30 000 search steps, an energy window of 100 kJ mol À1 for saving structures, the loosened threshold for conformer redundancy:R MSD cutoff of 1.0 . From the minima conformations found in the step, six conformations of 2 N and 7c onformations of 2 C within 20 kJ mol À1 conformational gap energy from global minima were superposed to the binding conformations in the taxol-binding pocket by alignment in the core hairpin motif (PGGGSVQIV) ( Figure S6 ). The RMSD values of the core hairpin motif between the tubulin-binding conformations and the minima conformations were within 3.45-3.71 for 2 N and 4.00-5.60 for 2 C . 
Synthesis of peptides
Estimation of bindingaffinity by equilibriumdialysis
Aqueous solution (20 mL) containing 1 mm 1 N -TMR, 1 C -TMR, 2 N -TMR,o r2 C -TMR and 0, 2, 4, 6, 8, 10, 20, or 50 mm tubulin in BRB80 buffer was incubated at 25 8Cf or 30 min in the dark. The solution was dialyzed to equilibrium (24 h) against 1380 mLB RB80 buffer at 25 8Cu sing Xpress Micro Dialyzer MD100 (6-8 kDa cut-off, Scienova GmbH, Germany). The population of bound TMR-peptides to tubulin was calculated as DI/I 0 ,w here I 0 is the fluorescence intensity of the dialyzed bulk solution in the absence of tubulin, DI = I 0 ÀI,h ere I is the fluorescence intensity of the dialyzed bulk solution in the presence of each tubulin concentration. DI/I 0 was plotted as a function of tubulin concentration, and the K d and binding site occupancy n = DI max /I 0 ,w here DI max is as aturated fluorescence difference, were determined by fitting to aq uadratic binding function to Equation (1) using Excel and Solver. 
Preparation of Alexa Fluor 430-labeled tubulin (tubulin-AF)
Tubulin-AF was prepared using Alexa Fluor 430 NHS ester (Thermo Fisher Scientific) according to the standard procedure. [51] The labeling ratio of tubulin-AF was determined by measuring the absorbance of the protein and Alexa Fluor 430 at 280, and 430 nm, respectively.
Construction of TMR-peptide-incorporated microtubules
In the "Before" method, 1 N -TMR, 1 C -TMR, 2 N -TMR,o r2 C -TMR (375 mm,2mL) was added to as olution (6 mL) containing tubulin (33 mm)a nd tubulin-AF (33 mm)i nB RB80 buffer (80 mm PIPES pH 6.9, 1.0 mm MgCl 2 ,1 .0 mm EGTA). The mixture (8 mL) was kept at 25 8Cf or 30 min in the dark. Then 2 mLo fG MPCPP premix (1 mm GMPCPP,8 0mm PIPES pH 6.9, 21 mm MgCl 2 ,1 .0 mm EGTA) was added to the mixture and kept at 37 8Cf or 30 min in the dark. The mixture was diluted 10-fold with BRB80 buffer and used for CLSM imaging. For inhibition experiments with taxol, the mixture was diluted 10-fold with various concentrations of taxol in BRB80 buffer.I nt he "After" method, GMPCPP premix (2 mL) was added to as olution (6 mL) containing tubulin (33 mm)a nd tubulin-AF (33 mm) in BRB80 buffer.T he mixture (8 mL) was kept at 37 8Cf or 30 min in the dark. Then 1 N -TMR, 1 C -TMR, 2 N -TMR,o r2 C -TMR (375 mm,2mL) was added to the mixture and kept at 25 8Cf or 30 min in the dark. The mixture was diluted 10-fold with BRB80 buffer and used for CLSM imaging. For inhibition experiments with taxol, the mixture was diluted 10-fold by various concentrations of taxol in BRB80 buffer.
CLSM measurements
The glass bottom dishes (Matsunami, Osaka, Japan) were coated with 1mgmL
À1 poly-l-lysine (Mw: 30000-70000, Sigma) at RT for 1h,t hen removed and dried. The microtubule samples were put on the plate and kept at RT for 1h,t hen observed by CLSM. Tubulin-AF was excited with 428 nm and observed through a5 36 nm emission band-pass filter (Green). TMR-labeled peptide was excited with 550 nm and observed through a5 74 nm emission band-pass filter (Red). AF and TMR fluorescence intensity per microtubule were measured from the fluorescence images by subtracting the background intensity using ImageJ software. The background-subtracted TMR fluorescence intensity per AF fluorescence intensity for each microtubule (N = 10) was calculated to estimate the binding of TMR-peptides to microtubules from at least three images.
Treatment of anti-tubulinantibody
Anti-b-tubulin, monoclonal antibody (Wako, Japan) in the antibody buffer (10 mm sodium phosphate buffer pH 7.4, 150 mm NaCl, 50 %( w/v) glycerol) was used. In the "Before" method, the anti-tubulin antibody in the antibody buffer (0.5 mg mL À1 ,3mL) or the antibody buffer (3 mL) was added to as olution (3 mL) containing tubulin (67 mm)a nd tubulin-AF (67 mm)i nB RB80 buffer and kept at 25 8Cf or 60 min in the dark. 1 N -TMR, 1 C -TMR, 2 N -TMR,o r2 C -TMR (375 mm,2mL) was added to the mixture and kept at 25 8Cf or 30 min in the dark. Then 2 mLo fG MPCPP premix was added to the mixture and kept at 37 8Cf or 30 min in the dark. The mixture was diluted 10-fold with BRB80 buffer and used for CLSM imaging. In the "After" method, GMPCPP premix (2 mL) was added to as olution (3 mL) containing tubulin (67 mm)a nd tubulin-AF (67 mm)i n BRB80 buffer.T he mixture (5 mL) was kept at 37 8Cf or 30 min in the dark. The anti-tubulin antibody in the antibody buffer (0.5 mg mL À1 ,3mL) or the antibody buffer (3 mL) was added to the mixture and kept at 25 8Cf or 60 min in the dark. 1 N -TMR, 1 C -TMR, 2 N -TMR,o r2 C -TMR (375 mm,2mL) was added to the mixture and kept at 25 8Cf or 30 min in the dark. The mixture was diluted 10-fold with BRB80 buffer and used for CLSM imaging.
Turbidity measurement
Turbidity experiments were performed with 4 mm tubulin and 1mm GTP in the absence or presence of 10 mm taxol, 1 N , 1 C , 2 N ,o r 2 C in BRB80 buffer at 37 8C. Optical density at 350 nm was monitored with aU V/Vis spectrometer for 60 min at 1min intervals. After 60 min measurements, the samples were cooled at 4 8Cf or 15 min and the optical density was measured again.
Encapsulation of 2 N -AuNP conjugates in microtubules
The mixture of 50 mm 2 N and 5 mm AuNP (Sigma, 5nm, stabilized suspension in citrate buffer) was incubated at 25 8Cf or 60 min to construct 2 N -AuNP conjugates. The mixture (5 mL) of the 2 N -AuNP conjugates (0.2 mm AuNP,2 mm 2 N )a nd 2 mm tubulin in BRB80 buffer was kept at 25 8Cf or 30 min. GMPCPP premix (2 mL) was added to the mixture and kept at 37 8Cf or 30 min. The anti-tubulin antibody in the antibody buffer (0.5 mg mL À1 ,3mL) or the antibody buffer (3 mL) was added to the mixture and kept at 25 8Cf or 60 min in the dark. The solution was put on ap ositively-charged C-SMART Plus TEM grid (ALLIANCE Biosystems Inc.), allowed to stand for 1min, and then removed. Given that 2% phosphotungstic acid (Na 3 (PW 12 O 40 )( H 2 O) n )a queous solution was not suitable for staining of microtubules, the grid was exposed to 2% Gd(CH 3 CO 2 ) 3 (H 2 O) n aqueous solution (5 mL) for staining, which was allowed to stand for 1min, and then removed. The resulting grid was dried in vacuo and observed by TEM using an accelerating voltage of 80 kV.
